Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".

Authors

Nirav H Shah, Swedish Neuroscience Institute, Seattle, WA.

Document Type

Article

Publication Date

9-1-2017

Publication Title

Stroke; a journal of cerebral circulation

Keywords

Brain Ischemia; Fibrinolytic Agents; Humans; Pipecolic Acids; Recombinant Proteins; Stroke; Tissue Plasminogen Activator; Treatment Outcome

Clinical Institute

Neurosciences (Brain & Spine)

Department

Neurosciences

Recommended Citation

Shah, Nirav H, "Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)"." (2017). Articles, Abstracts, and Reports. 2311.
https://digitalcommons.providence.org/publications/2311